MHM Magazine

10 | MENTAL HEALTH MATTERS | 2023 | Issue 3 MHM References: 1 . Deslafore XR 50 and 100, extended-release tablets Professional Information, December 2020. 2 . Osuch E, Marais A. The Pharmacological management of Depression - Update 2017. S Afr Fam Pract 2017;59(1):6-16. 3 . Colvard MD. Key differences between Venlafaxine XR and Desvenlafaxine: An analysis of pharmacokinetic and clinical data. Mental Health Clin 2014;4(1):35-39. 4 . Database of Medicine Prices, 24 December 2021. Department of Health. Available from: http://www.mpr.gov.za. [Accessed 10 January 2022]. For full prescribing information please refer to the Professional Information approved by SAHPRA (South African Health Products Regulatory Authority). S5 Deslafore XR 50 Tablets. Each extended-release tablet contains desvenlafaxine succinate monohydrate equivalent to 50 mg desvenlafaxine. Reg. No.: 52/1.2/0505. S5 Deslafore XR 100 Tablets. Each extended-release tablet contains desvenlafaxine succinate monohydrate equivalent to 100 mg desvenlafaxine. Reg. No.: 52/1.2/0506. Adcock Ingram Limited. Co. Reg. No.: 1949/034385/06. 1 New Road, Midrand, 1685. Private Bag X69, Bryanston, 2021. Customer Care: 0860 ADCOCK/232625. www.adcock.com 2022021810185341. March 2022. MDD - major depressive disorder New Deslafore XR 50 and XR 100 1 • First-line for the treatment of depressive symptoms, adults ≥ 18 years of age 1,2 • Convenient once daily dosing 1 • Limited clinically significant drug interactions 3 • 25 % Monthly saving vs. originator 4 A helping hand NEW Deslafore Desvenlafaxine succinate monohydrate When your MDD patients need it most 1 17136